CheckMate-032: Phase I/II open-label study of safety and activity of nivolumab (nivo) alone or with ipilimumab (ipi) in advanced and metastatic (A/M) gastric cancer (GC) Meeting Abstract
| Authors: | Janjigian, Y. Y.; Bendell, J. C.; Calvo, E.; Kim, J. W.; Ascierto, P. A.; Sharma, P.; Ott, P. A.; Bono, P.; Jaeger, D.; Evans, T. R. J.; De Braud, F. G.; Chau, I.; Tschaika, M.; Harbison, C. T.; Lin, C. S.; Le, D. T. |
| Abstract Title: | CheckMate-032: Phase I/II open-label study of safety and activity of nivolumab (nivo) alone or with ipilimumab (ipi) in advanced and metastatic (A/M) gastric cancer (GC) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 208s |
| Language: | English |
| ACCESSION: | WOS:000404665405236 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.4010 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4010 -- Source: Wos |
